On the one hand, predominance of the AngII/AT1 receptor arm of RAAS as well as increased MAPK activity in CVD could enhance viral pathogenesis and thus predispose the patients for increased COVID-19 severity. This evidence concerns the gene AGTR1 and COVID-19.